Not finding it? Sign in to also search OpenAlex live.
-
#2318 A novel cardiovascular-kidney-metabolic syndrome mouse model with inducible HFrEF and atherosclerosis2025 Nephrology Dialysis Transplantation article Medicine Chronic Kidney Disease and Diabetes Open access
Arianne van Koppen, Anke M. Smits, Tri Quang Nguyen, Amélie Dendooven, Ingeborg M. Bajema, Harry van Goor, +5 more
0citations -
Cardiac arrhythmias in Dravet syndrome: an observational multicenter study2020 Annals of Clinical and Translational Neurology article Medicine Epilepsy research and treatment Open access
Sharon Shmuely, Rainer Surges, Robert M. Helling, W. Boudewijn Gunning, Eva H. Brilstra, Judith S. Verhoeven, +5 more
29citations -
Abstract CT286: TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in combination with pembrolizumab vs pembrolizumab alone in treatment-naive unresectable or metastatic melanoma
Sajeve Samuel Thomas, Young Ki Hong, Yazan Samhouri, James Larkin, Gino Kim In, Victoria G. Atkinson, +21 more
2citations -
Transport‐controlled growth decoupling for self‐induced protein expression with a glycerol‐repressible genetic circuit2024 Biotechnology and Bioengineering article Biochemistry, Genetics and Molecular Biology Microbial Metabolic Engineering and Bioproduction Open access
Alvaro R. Lara, Flavio Kunert, Vincent Vandenbroucke, Hilal Taymaz‐Nikerel, Luz María Martínez, Juan‐Carlos Sigala, +3 more
1citations -
Genome-driven elucidation of phage-host interplay and impact of phage resistance evolution on bacterial fitness2021 The ISME Journal article Environmental Science Bacteriophages and microbial interactions Open access
Paweł Markwitz, Cédric Lood, Tomasz Olszak, Vera van Noort, Rob Lavigne, Zuzanna Drulis‐Kawa
72citations -
778 TILVANCE-301, a phase 3 study of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy combined with pembrolizumab (pembro) vs pembro alone in treatment-naïve unresectable or metastatic melanoma2023 Regular and Young Investigator Award Abstracts conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access cited by 2 patents
Daniel J. Olson, James Larkin, Young Ki Hong, Sajeve Samuel Thomas, Juan Martín-Liberal, Andrew J.S. Furness, +13 more
3citations -
Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.2024 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management Open access
Christian U. Blank, Minke W. Lucas, Richard A. Scolyer, Bart A. van de Wiel, Alexander Maxwell Menzies, Marta López‐Yurda, +14 more
27citations -
Abstract CT021: Preliminary clinical results of a therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with stage IV NSCLC2024 Cancer Research conference-abstract Immunology and Microbiology Immunotherapy and Immune Responses
Willemijn S.M.E. Theelen, Maurice Pérol, Kristof Cuppens, Ingel Demedts, Frank Borm, Bonne Biesma, +17 more
3citations -
Switch Control Inhibition of KIT and PDGFRA in Patients With Advanced Gastrointestinal Stromal Tumor: A Phase I Study of Ripretinib2020 Journal of Clinical Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access
Filip Jankú, Albiruni R. Abdul Razak, Ping Chi, Michael Charles Heinrich, Margaret von Mehren, Robin L. Jones, +10 more
91citations -
Efficacy of encorafenib plus binimetinib in patients with BRAF-mutated melanoma brain metastases: Results from the Dutch Melanoma Treatment Registry2025 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Melanoma and MAPK Pathways Open access
Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, C.U. Blank, Willeke A.M. Blokx, Marye J. Boers‐Sonderen, +13 more
7citations -
Benchmarking Variational AutoEncoders on cancer transcriptomics data2023 bioRxiv (Cold Spring Harbor Laboratory) preprint Biochemistry, Genetics and Molecular Biology Gene expression and cancer classification Open access
Mostafa Eltager, Tamim Abdelaal, Mohammed Charrout, Ahmed Essam Mahfouz, Marcel J. T. Reinders, Stavros Makrodimitris
4citations -
Effects of flow and polycystin‐1 dysfunction on ATP release in the inner medullary collecting duct of the kidney2022 The FASEB Journal article Biochemistry, Genetics and Molecular Biology Genetic and Kidney Cyst Diseases
Wouter H. van Megen, Charlotte R. M. M. van Waes, Dorien J.M. Peters, Jenny van der Wijst, Joost G.J. Hoenderop
0citations -
The pathway alteration load as a pan-cancer determinant of outcome of targeted therapies: Results from the Drug Rediscovery Protocol (DRUP).2024 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics
Karlijn Verkerk, Laurien Joanna Zeverijn, Joris van de Haar, Paul Roepman, Birgit S. Geurts, Ilse A.C. Spiekman, +9 more
0citations -
119MO Phase I/II trial evaluating the innovative therapeutic cancer vaccine PDC*lung01 in combination with anti-PD-1 in patients (pts) with untreated stage IV non-small cell lung cancer2024 Immuno-Oncology Technology article Immunology and Microbiology Immunotherapy and Immune Responses Open access
J.F. Vansteenkiste, Kristof Cuppens, I. Demedts, F. Borm, B. Biesma, Maurice Pérol, +13 more
0citations -
Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial2026 Blood Cancer Journal article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Steffen Koschmieder, Susanne Isfort, Lino Lars Teichmann, Philippe Schafhausen, Florian Heinrich Heidel, Carl C. Crodel, +22 more
0citations -
Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades
Florien Willemijn Boele, Patricia WM den Otter, Jaap C. Reijneveld, Philip C. De Witt Hamer, Hinke F. van Thuijl, Linda M.C. Lorenz, +7 more
35citations